pubmed-article:18704990 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C0345905 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C0221464 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C0796679 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:18704990 | lifeskim:mentions | umls-concept:C1519810 | lld:lifeskim |
pubmed-article:18704990 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:18704990 | pubmed:dateCreated | 2008-9-24 | lld:pubmed |
pubmed-article:18704990 | pubmed:abstractText | The role of transcatheter arterial chemoembolization (TACE) or transcatheter arterial chemoinfusion (TACI) for unresectable intrahepatic cholangiocarcinoma (ICC) has recently been questioned. The aim of the study was to evaluate the clinical efficacy of TACE or TACI in patients with unresectable ICC and to identify prognostic factors associated with clinical success. | lld:pubmed |
pubmed-article:18704990 | pubmed:language | eng | lld:pubmed |
pubmed-article:18704990 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18704990 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:18704990 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18704990 | pubmed:month | Oct | lld:pubmed |
pubmed-article:18704990 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:SongHo-YoungH... | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:YoonHyun-KiHK | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:SungKyu-BoKB | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:ShinJi HoonJH | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:KoGi-YoungGY | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:KimJin... | lld:pubmed |
pubmed-article:18704990 | pubmed:author | pubmed-author:GwonDong IlDI | lld:pubmed |
pubmed-article:18704990 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18704990 | pubmed:day | 1 | lld:pubmed |
pubmed-article:18704990 | pubmed:volume | 113 | lld:pubmed |
pubmed-article:18704990 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18704990 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18704990 | pubmed:pagination | 1614-22 | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:meshHeading | pubmed-meshheading:18704990... | lld:pubmed |
pubmed-article:18704990 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18704990 | pubmed:articleTitle | Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes. | lld:pubmed |
pubmed-article:18704990 | pubmed:affiliation | Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. | lld:pubmed |
pubmed-article:18704990 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18704990 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18704990 | lld:pubmed |